Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)

Clinical trial NCT03582449 · COMPLETED

Trial details

NCT number: NCT03582449
Sponsor: Shire
Status: COMPLETED
Study type: OBSERVATIONAL

Hunter Syndrome

Start date: 2018-01-19
Primary completion: 2020-05-10
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.